XML 94 R79.htm IDEA: XBRL DOCUMENT v3.25.1
Debt (Details)
 12 Months Ended
Mar. 31, 2025
USD ($)
Days
Director
Person
$ / shares
shares
Mar. 31, 2024
USD ($)
$ / shares
Mar. 31, 2023
USD ($)
$ / shares
Mar. 30, 2029
USD ($)
Amended Credit Facility [Abstract]        
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Convertible notes, related party Convertible notes, related party    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Convertible notes, related party Convertible notes, related party    
Change in fair value of compound net derivative liability $ (60,000) $ 1,020,000 $ 0  
Credit Facility [Member]        
Amended Credit Facility [Abstract]        
Maximum borrowing capacity $ 268,620,000      
Debt instrument, maturity date Dec. 12, 2028      
Percentage of aggregate revolving commitments 22.50%      
Revolving Facility [Member]        
Amended Credit Facility [Abstract]        
Interest rate at end of period 7.46% 8.43%    
Revolving Facility [Member] | Credit Facility [Member]        
Amended Credit Facility [Abstract]        
Maximum borrowing capacity $ 238,620,000      
Outstanding balance under revolving loan 90,787,000 $ 128,000,000    
Amount available under revolving facility 135,150,000      
Revolving Facility [Member] | Letters of Credit [Member]        
Amended Credit Facility [Abstract]        
Outstanding balance under revolving loan 7,047,000      
Term Loans [Member] | Credit Facility [Member]        
Amended Credit Facility [Abstract]        
Maximum borrowing capacity $ 30,000,000      
Convertible Notes [Member]        
Amended Credit Facility [Abstract]        
Debt instrument, maturity date Mar. 30, 2029      
Interest rate at end of period 10.00% 10.00% 10.00%  
Principal amount of convertible notes $ 35,209,000 $ 32,000,000 $ 32,000,000  
Interest paid in-kind $ 3,209,000      
Aggregate proceeds from offering     $ 31,280,000  
Number of shares issuable upon conversion 66.6667 66.6667 66.6667  
Base principal amount for debt to equity conversion $ 1,000 $ 1,000 $ 1,000  
Conversion price (in Dollars per share) | $ / shares $ 15 $ 15 $ 15  
Common stock available to be issued (in Shares) | shares 28,240,973      
Warrants maturity date Mar. 30, 2029      
Consecutive days prior to the redemption (in Days) | Days 20      
Maximum volume weighted average price of common stock (in Dollars per share) | $ / shares $ 15      
Warrants fair value $ 0 $ 0    
Return of Interest 15.00%      
Additional amount to be paid for redemption $ 5,000,000      
Minimum adjusted EBITDA for redemption 80,000,000      
Additional amount to be paid for weighted average price is less than $15 2,000,000      
Derivative liability 9,000,000 9,800,000    
Derivative assets 1,530,000 2,390,000    
Change in fair value of compound net derivative liability (60,000) 1,020,000    
Threshold aggregate payment in event of default 25,000,000      
Threshold Amount, Senior Debt Acceleration in Event of Default $ 25,000,000      
Cure period 30 days      
Notice period in the events of default 5 days      
Less: unamortized debt discount attributed to debt issuance costs $ 916,000 $ 1,058,000    
Debt Instrument, Interest Rate, Effective Percentage 18.30% 18.30%    
Debt issuance costs allocated to the bifurcated derivatives     $ 360,000  
Number directors the Purchaser Representative may nominate (in Director) | Director 1      
Number of persons having observation rights (in Person) | Person 1      
Forecast [Member] | Convertible Notes [Member]        
Amended Credit Facility [Abstract]        
Total payments       $ 56,704,000